|
In-Person Registration | What Clinicians Want to Know: Addressing Current Questions and Controversies Regarding the Role of CAR T-Cell Therapy and Bispecific Antibodies in the Management of LymphomaThis activity is intended for hematologists, medical oncologists and other healthcare providers involved in the treatment of lymphoma. You are now registering as a practicing physician, fellow, pharmacist, nurse or other healthcare provider involved in the treatment of cancer. If you are not a clinician in practice, please register as a nonclinician. |